Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Transplantation|February 11, 2010
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejectionR Carlin Walsh, Jason J Everly, Paul Brailey, et al.
Transplantation|April 10, 2015
Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft SurvivalJill C Krisl, Rita R Alloway, Adele Rike Shield, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2001
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainageA Lo, R J Stratta, D K Hathaway, et al.
Plos Medicine|November 15, 2017
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trialRita R Alloway, Alexander A Vinks, Tsuyoshi Fukuda, et al.
Transplantation Proceedings|April 26, 2005
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimensE S Woodle, B Susskind, R R Alloway, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxisA Lo, R J Stratta, M F Egidi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 5, 2023
The expanded role of the transplant pharmacist: A 10-year follow-upAlicia Beth Lichvar, Mary Moss Chandran, Elizabeth A Cohen, et al.
Clinical Transplantation|May 25, 2021
A call for transplant stewardship: The need for expanded evidence-based evaluation of induction and biologic-based cost-saving strategies in kidney transplantation and beyondMargaret R Jorgenson, Jillian L Descourouez, Bethany L Brady, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation Proceedings|April 26, 2005
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantationC C Rogers, R R Alloway, R Boardman, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Transplantation|February 11, 2010
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejectionR Carlin Walsh, Jason J Everly, Paul Brailey, et al.
Transplantation|April 10, 2015
Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft SurvivalJill C Krisl, Rita R Alloway, Adele Rike Shield, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2001
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainageA Lo, R J Stratta, D K Hathaway, et al.
Plos Medicine|November 15, 2017
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trialRita R Alloway, Alexander A Vinks, Tsuyoshi Fukuda, et al.
Transplantation Proceedings|April 26, 2005
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimensE S Woodle, B Susskind, R R Alloway, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxisA Lo, R J Stratta, M F Egidi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 5, 2023
The expanded role of the transplant pharmacist: A 10-year follow-upAlicia Beth Lichvar, Mary Moss Chandran, Elizabeth A Cohen, et al.
Clinical Transplantation|May 25, 2021
A call for transplant stewardship: The need for expanded evidence-based evaluation of induction and biologic-based cost-saving strategies in kidney transplantation and beyondMargaret R Jorgenson, Jillian L Descourouez, Bethany L Brady, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation Proceedings|April 26, 2005
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantationC C Rogers, R R Alloway, R Boardman, et al.
Pageof 17